Barclays lowers CVS Health (NYSE:CVS) price target from $89 to $86

By / / Barclays, CVS Health

Barclays analyst Steve Valiquette maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $89 to $86.

Scroll to Top